Picture of Puma Biotechnology logo

PBYI — Puma Biotechnology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Brief: Puma Biotechnology Says Jury Verdict Was Entered In Favor Of Wyeth, And Against Astrazeneca

May 17 (Reuters) - AstraZeneca PLC  AZN.L :
    * PUMA BIOTECHNOLOGY INC - JURY VERDICT WAS ENTERED IN FAVOR
OF
WYETH, AND AGAINST ASTRAZENECA
    * PUMA BIOTECHNOLOGY INC - JURY FOUND '314 & '162 PATENTS TO
BE
INFRINGED BY ASTRAZENECA AND NOT INVALID, AWARDED PLAINTIFFS
$107.5 MILLION IN DAMAGES

Source text for Eikon:  ID:n0001437749-24-017504 
Further company coverage:  AZN.L 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Puma Biotechnology

See all news